Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01376310
Title GSK1120212 Rollover Study
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

Docetaxel + Trametinib

Erlotinib + Trametinib

Trametinib

Pemetrexed Disodium + Trametinib

Carboplatin + Trametinib

Nab-paclitaxel + Trametinib

Gemcitabine + Trametinib

Everolimus + Trametinib

Age Groups: senior | adult
Covered Countries USA | FRA | CAN


No variant requirements are available.